Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS · Delayed Price · Currency is USD
0.0101
+0.0001 (1.00%)
At close: Jul 24, 2026
Nymox Pharmaceutical Market Cap
Nymox Pharmaceutical has a market cap or net worth of $1.06 million as of July 29, 2026. Its market cap has decreased by -85.97% in one year.
Market Cap
1.06M
Enterprise Value
4.27M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
ChartMarket Cap Chart
Since November 26, 1997, Nymox Pharmaceutical's market cap has decreased from 118.04M to 1.06M, a decrease of -99.10%. That is a compound annual growth rate of -15.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 1.06M | -74.14% |
| Dec 31, 2025 | 4.10M | -56.61% |
| Dec 31, 2024 | 9.45M | -82.82% |
| Dec 29, 2023 | 55.03M | 86.49% |
| Dec 30, 2022 | 29.51M | -73.23% |
| Dec 31, 2021 | 110.23M | -42.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sirona Biochem | 1.35M |
| Neon Bloom | 1.33M |
| inTerra Resources | 1.30M |
| AXIM Biotechnologies | 1.22M |
| Abpro Holdings | 1.15M |
| Regenerative Medical Technology Group | 1.11M |
| Evofem Biosciences | 1.05M |
| Avenue Therapeutics | 944.73K |